155 related articles for article (PubMed ID: 30219449)
41. Mistletoe and cancer: controversies and perspectives.
Mansky PJ
Semin Oncol; 2002 Dec; 29(6):589-94. PubMed ID: 12516042
[TBL] [Abstract][Full Text] [Related]
42. Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Evid Based Complement Alternat Med; 2014; 2014():236310. PubMed ID: 24955100
[TBL] [Abstract][Full Text] [Related]
43. Interaction of a standardized mistletoe (Viscum album) preparation with antitumor effects of Trastuzumab in vitro.
Weissenstein U; Kunz M; Urech K; Regueiro U; Baumgartner S
BMC Complement Altern Med; 2016 Aug; 16():271. PubMed ID: 27491866
[TBL] [Abstract][Full Text] [Related]
44. Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research.
Kienle GS; Glockmann A; Schink M; Kiene H
J Exp Clin Cancer Res; 2009 Jun; 28(1):79. PubMed ID: 19519890
[TBL] [Abstract][Full Text] [Related]
45. Mistletoe and gemcitabine in patients with advanced cancer: a model for the phase I study of botanicals and botanical-drug interactions in cancer therapy.
Mansky PJ; Grem J; Wallerstedt DB; Monahan BP; Blackman MR
Integr Cancer Ther; 2003 Dec; 2(4):345-52. PubMed ID: 14713326
[TBL] [Abstract][Full Text] [Related]
46. Sensitization of K562 Leukemia Cells to Doxorubicin by the Viscum album Extract.
Srdic-Rajic T; Tisma-Miletic N; Cavic M; Kanjer K; Savikin K; Galun D; Konic-Ristic A; Zoranovic T
Phytother Res; 2016 Mar; 30(3):485-95. PubMed ID: 26692465
[TBL] [Abstract][Full Text] [Related]
47. Comparative study on the effects of aqueous extracts of viscum album (mistletoe) from three host plants on hematological parameters in albino rats.
Ladokun O; Ojezele M; Arojojoye O
Afr Health Sci; 2015 Jun; 15(2):606-12. PubMed ID: 26124810
[TBL] [Abstract][Full Text] [Related]
48. Study on local inflammatory reactions and other parameters during subcutaneous mistletoe application in HIV-positive patients and HIV-negative subjects over a period of 18 weeks.
Stoss M; van Wely M; Musielsky H; Gorter RW
Arzneimittelforschung; 1999 Apr; 49(4):366-73. PubMed ID: 10337457
[TBL] [Abstract][Full Text] [Related]
49. Phytochemical profile and therapeutic potential of Viscum album L.
Nazaruk J; Orlikowski P
Nat Prod Res; 2016; 30(4):373-85. PubMed ID: 25813519
[TBL] [Abstract][Full Text] [Related]
50. Additional treatment with mistletoe extracts for patients with breast cancer compared to conventional cancer therapy alone - efficacy and safety, costs and cost-effectiveness, patients and social aspects, and ethical assessment.
Schnell-Inderst P; Steigenberger C; Mertz M; Otto I; Flatscher-Thöni M; Siebert U
Ger Med Sci; 2022; 20():Doc10. PubMed ID: 36160875
[TBL] [Abstract][Full Text] [Related]
51. Cancer Patients' Experiences of Using Mistletoe (Viscum album): A Qualitative Systematic Review and Synthesis.
Evans M; Bryant S; Huntley AL; Feder G
J Altern Complement Med; 2016 Feb; 22(2):134-44. PubMed ID: 26684278
[TBL] [Abstract][Full Text] [Related]
52. [Postoperative Viscum album therapy after surgery of breast neoplasms].
Leroi R
Helv Chir Acta; 1977 Jun; 44(3):403-14. PubMed ID: 617173
[TBL] [Abstract][Full Text] [Related]
53. Clinical characteristics and therapeutic behavior of breast cancer patients using mistletoe therapy consulting a clinic offering integrative oncology: a registry data analysis.
Krüerke D; Schenker M; Matter-Walstra K
BMC Complement Med Ther; 2023 Nov; 23(1):395. PubMed ID: 37924102
[TBL] [Abstract][Full Text] [Related]
54. Complete Remission and Long-term Survival of a Patient with a Diffuse Large B-cell Lymphoma Under
Gutsch J; Werthmann PG; Rosenwald A; Kienle GS
Anticancer Res; 2018 Sep; 38(9):5363-5369. PubMed ID: 30194190
[TBL] [Abstract][Full Text] [Related]
55. Molecular mechanisms of mistletoe plant extract-induced apoptosis in acute lymphoblastic leukemia in vivo and in vitro.
Seifert G; Jesse P; Laengler A; Reindl T; Lüth M; Lobitz S; Henze G; Prokop A; Lode HN
Cancer Lett; 2008 Jun; 264(2):218-28. PubMed ID: 18314258
[TBL] [Abstract][Full Text] [Related]
56. Synergistic Antitumour Properties of
Stammer RM; Kleinsimon S; Rolff J; Jäger S; Eggert A; Seifert G; Delebinski CI
J Immunol Res; 2017; 2017():4874280. PubMed ID: 28791312
[TBL] [Abstract][Full Text] [Related]
57. Chemoimmunotherapy in Advanced Renal Cell Carcinoma: A Case Report of a Long-Term Survivor Adjunctly Treated with Viscum album Extracts.
Werthmann PG; Kindermann L; Kienle GS
Complement Med Res; 2019; 26(4):276-279. PubMed ID: 30897582
[TBL] [Abstract][Full Text] [Related]
58. Proteomic fingerprinting of mistletoe (Viscum album L.) via combinatorial peptide ligand libraries and mass spectrometry analysis.
Vergara-Barberán M; Lerma-García MJ; Nicoletti M; Simó-Alfonso EF; Herrero-Martínez JM; Fasoli E; Righetti PG
J Proteomics; 2017 Jul; 164():52-58. PubMed ID: 28571969
[TBL] [Abstract][Full Text] [Related]
59. Course of mitogen-stimulated T lymphocytes in cancer patients treated with Viscum album extracts.
Büssing A; Stumpf C; Tröger W; Schietzel M
Anticancer Res; 2007; 27(4C):2903-10. PubMed ID: 17695469
[TBL] [Abstract][Full Text] [Related]
60. Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts.
Kienle GS; Kiene H
Eur J Med Res; 2007 Mar; 12(3):103-19. PubMed ID: 17507307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
